Serotonin Sensitivity and Withdrawal With Low-Dose Venlafaxine

Prim Care Companion CNS Disord. 2019 Feb 28;21(1):18l02334. doi: 10.4088/PCC.18l02334.
No abstract available

Publication types

  • Case Reports
  • Letter

MeSH terms

  • Anxiety Disorders / drug therapy
  • Delayed-Action Preparations
  • Humans
  • Male
  • Selective Serotonin Reuptake Inhibitors / adverse effects*
  • Selective Serotonin Reuptake Inhibitors / therapeutic use
  • Serotonin / therapeutic use
  • Serotonin Receptor Agonists / therapeutic use
  • Substance Withdrawal Syndrome / drug therapy
  • Substance Withdrawal Syndrome / etiology*
  • Venlafaxine Hydrochloride / adverse effects*
  • Venlafaxine Hydrochloride / therapeutic use
  • Young Adult

Substances

  • Delayed-Action Preparations
  • Serotonin Receptor Agonists
  • Serotonin Uptake Inhibitors
  • Serotonin
  • Venlafaxine Hydrochloride